Presenters

Mark R. Schleiss | POC-Point of Contact, Primary Presenter, Author

schleiss@umn.edu ;
Dr. Schleiss is a Professor of Pediatrics and holds the American Legion and Auxiliary Endowed Research Chair at the University of Minnesota Medical School. His laboratory is supported by the NIH. He conducts research in small animal models testing vaccine strategies against congenital CMV infection. His laboratory is also engaged in the study of the epidemiology, pathogenesis and management of congenital and neonatal CMV infections.

---

Erin Osterholm | Co-Author

oste0123@umn.edu;
Dr. Osterholm is Medical Director of the Newborn Intensive Care Unit at the University of Minnesota Medical School and a faculty member in the Division of Neonatology. She is interested in the clinical implications of CMV on neurodevelopment in both preterm and term infants.

---

Rebecca Kruc | Co-Author

krucx003@umn.edu;
Rebecca Kruc MD, MPH is a resident in pediatrics at the Mayo College of Medicine. Her background is in public health. She previously worked in enteric infectious diseases at the Minnesota Department of Health. She also previously worked for the Centers for Disease Control in New York City doing tuberculosis control and prevention, as well as in Arizona doing public health emergency preparedness.

---

Nelmary Hernandez-Alvarado | Co-Author

hernande@umn.edu;
Ms. Hernandez-Alvarado is a molecular biology and Director of a CLIA-certified CMV diagnostic laboratory at the University of Minnesota. She has considerable expertise in detection of CMV and in the clinical manifestations of congenital and neonatal CMV infections.

---

Mark Blackstad | Co-Author

black114@umn.edu;
Mr. Blackstad is a molecular virologist and researcher with expertise in PCR-based diagnostics for cytomegalovirus.

---

Hannah Herd | Co-Author

eric3113@umn.edu ;
Dr. Herd is an audiologist at the University of Minnesota Masonic Children's Hospital where she maintains a data-base for hearing-impaired children, including those with congenital CMV infection.

---

Sondra Rosendahl | Co-Author

sondra.rosendahl@state.mn.us;
Sondra is a licensed genetic counselor who has been with the Minnesota Department of Health (MDH) Newborn Screening Program since 2011. Sondra is the coordinator of MDH’s Advisory Committee on Heritable and Congenital Disorders whose role is to provide advice and recommendations to the Minnesota Commissioner of Health concerning tests and treatments for disorders found in newborn children.

---

Kirsten Coverstone | Co-Author

kirsten.coverstone@state.mn.us;
Dr. Kirsten Coverstone is an audiologist at the Minnesota Department of Health (MDH) Newborn Screening Program. As a coordinator of Minnesota’s EHDI program, Kirsten has worked at the local, state, and national levels to support best practice for universal newborn screening, timely & complete audiologic follow-up for hearing, and early access to intervention. In addition, Kirsten implemented the statewide hearing instrument loaner program for infants and young children in Minnesota. Universal screening, education, and follow-up for congenital cytomegalovirus (cCMV) has been a longstanding aspiration as cCMV is the leading cause of non-genetic hearing loss and is intricately related to EHDI. She has served as Co-Chair of the Joint Committee on Infant Hearing (JCIH), & Co-Chair of the Center for Disease Control (CDC) EHDI Data Committee.

---

Sheila Dollard | Co-Author

sgd5@cdc.gov;
Sheila Dollard earned her PhD in Biochemistry from the University of Rochester Medical Center, Rochester NY. She joined the Centers for Disease Control and Prevention in 1998 as Team Leader for Herpesvirus Diagnostics where her work has focused on HHV-8 (human herpesvirus 8) and CMV epidemiology and diagnostic assay development to meet U.S. public health needs.

---

Tatiana Lanzieri | Co-Presenter, Author, Co-Author

uyk4@cdc.gov;
Tatiana M. Lanzieri, M.D., M.P.H., is a medical epidemiologist with the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention. She has over 20 years of experience in infectious disease epidemiology, surveillance, and outbreak investigation.